Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease

Zhu Zhang, Shiqing Zhang, Cathy Nga Ping Lui, Peili Zhu, Zhang Zhang, Kaili Lin, Yiwu Dai*, Ken Kin Lam Yung*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


The prevalence of multiple neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), has been dramatically increasing, particularly in the aging population. However, the currently available therapies merely alleviate the symptoms of these diseases and are unable to retard disease progression significantly. Traditional Chinese medicine (TCM) has been used in clinical practice for thousands of years for ameliorating symptoms or interfering with the pathogenesis of aging- associated diseases. Modern pharmacological studies have proved that TCM imparts disease-modifying therapeutic effects against these diseases, such as protection of neurons, clearance of protein aggregates, and regulation of neuroinflammation. This review summarizes the evidence from recent studies on AD and PD therapies regarding the neuroprotective activities and molecular mechanisms of a series of TCM formulations comprising herbs and their active ingredients. The findings of this review support the use of TCM as an alternative source of therapy for the treatment of neurodegenerative diseases.
Original languageEnglish
Pages (from-to)207-222
Number of pages16
JournalJournal of Neurorestoratology
Issue number4
Publication statusPublished - 5 Dec 2019

User-Defined Keywords

  • traditional Chinese medicine
  • Alzheimer’s disease
  • Parkinson’s disease
  • neurorestorative therapy


Dive into the research topics of 'Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease'. Together they form a unique fingerprint.

Cite this